Total Revenues of $759.0M, up 17% Year Over Year
Subscription Services Revenues of $634.8M, up 19% Year Over Year PLEASANTON, Calif., May 28, 2025 /PRNewswire/ -- Veeva Systems Inc. (NYSE: VEEV), a leading provider of industry cloud solutions for the global life sciences industry, today announced results for its first quarter ended April 30, 2025.
"I consider this our best first quarter ever. We executed with speed, quality, and innovation across... Read more
ALL-REMOTE COMPANY/WILMINGTON, Del. / May 28, 2025 / Business Wire / Phreesia, Inc. (NYSE: PHR) (“Phreesia” or the "Company") announced financial results today for the fiscal first quarter ended April 30, 2025.
"Our fiscal year 2026 is off to a strong start. I am grateful to our team for their continued commitment to our mission, vision and values. I believe our performance is a reflection of our team truly living our values,” said CEO and Co-Founder Chaim Indig.
Please... Read more
Strategic leadership and operational collaboration underscore Claritev’s commitment to growth in the Middle East and international business development outside the US MCLEAN, Va. & ABU DHABI, United Arab Emirates / May 28, 2025 / Business Wire / Claritev Corporation (“Claritev”) (NYSE: CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today announced it is deepening its investment in the... Read more
Dallas, TX, May 27, 2025 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) ("Mangoceuticals" or the "Company"), a company focused on developing, marketing, and selling a variety of health and wellness products via a secure telemedicine platform under the brands MangoRx and PeachesRx, and a pioneer in innovative wellness solutions, is excited to share groundbreaking results from field studies based on its patented antiviral compound which it refers to as “MGX-0024”.... Read more
This agreement follows the previous announcement of a memorandum of understanding signed last month. MCLEAN, Va. & ABU DHABI, United Arab Emirates / May 22, 2025 / Business Wire / Claritev Corporation (“Claritev”) (NYSE: CTEV) and Claims Care Revenue Cycle Management LLC (“Claims Care” or “CCRCM”), a division of Burjeel Holdings (ADX: BURJEEL), are pleased to announce the formalization of their strategic relationship, following the signing of a memorandum... Read more
NEW YORK / May 22, 2025 / Business Wire / Schrödinger, Inc. (Nasdaq: SDGR) today announced that management will participate in a fireside chat at the Jefferies Global Healthcare Conference. The live presentation will take place on Wednesday, June 4, 2025 at 1:25 p.m. E.T.
The live webcast can be accessed in the “Investors” section of Schrödinger’s website and will be archived for approximately 90 days following the event.
About Schrödinger
Schrödinger is transforming... Read more
Company deploying AI to scale industry-leading rare disease dataset to diagnose growing number of patients with genetic disease, published in the American Journal of Medical Genetics GAITHERSBURG, Md. / May 22, 2025 / Business Wire / GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced the publication of a new article in the American Journal of Medical Genetics, demonstrating GeneDx’s leadership in applying... Read more
SAN FRANCISCO / May 21, 2025 / Business Wire / Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced that Jeff Tangney, co-founder and CEO, will present at the William Blair 45th Annual Growth Stock Conference on Tuesday, June 3, 2025 at 4:40 p.m. Central Time.
About Doximity
Founded in 2010, Doximity is the leading digital platform for U.S. medical professionals. The company's network members include more than 80% of... Read more
Singapore, Singapore--(Newsfile Corp. - May 20, 2025) - Mobile-health Network Solutions (Nasdaq: MNDR) ("MNDR" or "the Company"), a leading MedTech innovator ranked among Asia-Pacific's high-growth companies, today unveiled a new tele-dentistry service that is soon expected to let patients perform an AI-enhanced dental scan at home using the Company's MaNaDr telemedicine app, with expert-reviewed reports delivered within 24 hours.
The service, which MNDR will market to... Read more
Delivers pre-configured, pre-validated software that can scale with the needs of fast-growing companies PLEASANTON, Calif., May 20, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that Veeva Basics is being used by more than 75 biotechs to gain efficiency and reduce costs across clinical, regulatory, and quality. With standardized applications, biotechs are going live with industry-leading software in weeks and gaining a system that can scale as they... Read more
USC Spine Center, part of Keck Medicine of USC, specializes in treating complex spine conditions with the latest cutting-edge technologies
CLARITY is a randomized clinical trial designed to demonstrate Nociscan’s ability to improve surgical outcomes for chronic low back pain
Nociscan aims to become the gold standard in identifying sources of low back pain through MR Spectroscopy (MRS) and Augmented Intelligence (AI) BROOMFIELD, Colo., May 20, 2025 (GLOBE NEWSWIRE)... Read more
Q1 Revenue of $2.0 million, down 25% year over year
Q1 Operating loss of $(5.9) million, a 37% increase year over year
Q1 Adjusted EBITDA of $(4.3) million, a 28% decline year over year
Company announces securing a $10.0 million financing commitment from Acuitas Capital LLC
Company announces recertification by the National Committee for Quality Assurance (NCQA) as a Credentials Verification Organization (CVO)
Company to Host Conference Call at 4:30 pm ET Today MIAMI... Read more
MOBILE, Ala. / May 19, 2025 / Business Wire / TruBridge, Inc. (NASDAQ:TBRG), a leading healthcare solutions company, today announced the integration of Microsoft Dragon Copilot with its electronic health record (EHR) solution. Collaboration between the two technologies will enhance care delivery, financial stability, and operational efficiency for thousands of hospitals and health systems across the country.
Microsoft Dragon Copilot will empower more than 18,000 TruBridge... Read more
BEIJING, May 16, 2025 /PRNewswire/ -- So-Young International Inc. (Nasdaq: SY) ("So-Young" or the "Company"), the leading aesthetic treatment platform in China connecting consumers with online services and offline treatments, today announced its unaudited financial results for the first quarter ended March 31, 2025.
First Quarter 2025 Financial Highlights Total revenues were RMB297.3 million (US$41.0 million[1]), compared with RMB318.3 million in... Read more
Q4 total revenues of $138.3 million, up 17% year-over-year
Q4 operating cash flow of $98.5 million, up 54% year-over-year
Q4 free cash flow of $97.0 million, up 56% year-over-year
Fiscal year 2025 total revenues of $570.4 million, up 20% year-over-year
Fiscal year 2025 operating cash flow of $273.3 million, up 48% year-over-year
Fiscal year 2025 free cash flow of $266.7 million, up 50% year-over-year SAN FRANCISCO / May 15, 2025 / Business Wire / Doximity, Inc.... Read more
Singapore, Singapore--(Newsfile Corp. - May 15, 2025) - Mobile-health Network Solutions (NASDAQ: MNDR) ("MNDR" or "the Company"), a leading MedTech innovator ranked among Asia-Pacific's high-growth companies, today announced it will present at two upcoming conferences.
Co-CEOs and co-founders Dr. Tung Yeng Siaw and Dr. Rachel Teoh will present and host one-on-one meetings with investors at the Sidoti May Virtual Investor Conference, to be held May 21-22, 2025.
Their... Read more
CleaRecon DL receives 510(k) clearance and CE mark, paving the way for clinicians to use 3D image guidance technologies to their full potential with the goal of achieving better clinical and operational outcomes
AI-driven solution advances image quality and improves clinical confidence, encouraging adoption of cone-beam computed tomography CHICAGO / May 15, 2025 / Business Wire / GE HealthCare (Nasdaq: GEHC) today announced the launch of CleaRecon DL, technology powered... Read more
Newest version of the quantitative systems toxicology (QST) software supports drug-induced liver injury (DILI) prediction for pediatric patient populations RESEARCH TRIANGLE PARK, N.C. / May 15, 2025 / Business Wire / Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus”), a leading provider of cheminformatics, biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry, today announced the release... Read more
RFID-Enabled Dispensing and Intelligent Inventory Management Software Aim to Unlock Greater Inventory Accuracy and Streamline Medication Management in Operating Rooms and Outpatient Clinics FORT WORTH, Texas / May 14, 2025 / Business Wire / Omnicell, Inc. (Nasdaq:OMCL) (“Omnicell” or the “Company”), a leader in transforming the pharmacy and nursing care delivery model, today announced new products designed to streamline workflows and enhance inventory visibility... Read more
Company to host webcast to review data on Thursday, June 12, 2025 at 8:00 a.m. ET NEW YORK / May 14, 2025 / Business Wire / Schrödinger, Inc. (Nasdaq: SDGR) today announced that initial Phase 1 clinical data for SGR-1505, its investigational MALT1 inhibitor, will be presented at the European Hematology Association Annual Congress, taking place June 12 - 15, 2025, in Milan, Italy. Additional data from this trial will be presented at the International Conference on Malignant... Read more
Existing senior secured credit facility assigned to new investors; added $1.6 million of new senior secured financing, and settled $0.4 million owing to officers and directors for no cash consideration
Moving towards cash flow positive status within calendar 2025
Supports Newtopia's ability to facilitate sustainable metabolic health outcomes, proven cost savings and demonstrated positive ROI to GLP-1 sponsors
Highly scalable alongside the rise of Health AI: unique... Read more
The latest approval will help provide clearer echocardiogram images for cardiologists to diagnose heart conditions in pediatric patients
Optison is the only polyethylene glycol (PEG)-free ultrasound enhancing agent available in the U.S. ARLINGTON HEIGHTS, Ill. / May 13, 2025 / Business Wire / GE HealthCare (Nasdaq: GEHC) today announced the U.S. Food and Drug Administration (FDA) has approved a pediatric indication for the company’s Optison™ (Perflutren Protein-Type... Read more
Integration delivers high-value datasets including chargemaster, laboratory results and EMR data to accelerate clinical and commercial insights PHILADELPHIA, May 13, 2025 /PRNewswire/ -- HealthVerity, the leader in real-world data (RWD) technology and privacy-compliant data exchange, today announced the addition of Premier, Inc. (NASDAQ: PINC) to HealthVerity Marketplace™, meaning life sciences organizations using HealthVerity Marketplace™ can now access Premier's... Read more
The companies plan to co-develop solutions that support the integration of Raydiant Oximetry’s fetal pulse oximetry technology into GE HealthCare’s fetal monitoring and digital perinatal surveillance platforms that have a 60-year history of innovation and industry firsts.
Fetal pulse oximetry technology aims to provide real-time insights to clinicians during labor and delivery and improve the detection of fetal distress, potentially reducing newborn neurological injuries,... Read more
HEALWELL achieved quarterly revenue from continuing operations of $14.1 million in Q1-2025, 208% higher than the $4.6 million generated in Q1-2024. Revenue growth was driven by acquisitions in the past year and record growth of 224% in the Company's AI and Data Science business.
On April 1, 2025, HEALWELL completed the acquisition of Orion Health, which is expected to contribute approximately $100 million in annual SaaS and services revenue starting in Q2-2025 and propels... Read more
LEHI, Utah and LOUISVILLE, Ky., May 13, 2025 /PRNewswire/ -- Waystar Holding Corp. (Nasdaq: WAY) ("Waystar"), a provider of leading healthcare payments software, today announced a proposed underwritten public offering of 12,500,000 shares of its common stock being offered by certain investment funds of EQT AB and Bain Capital, LP, and Canada Pension Plan Investment Board (CPP Investments), and their respective affiliates (collectively, the "Selling Stockholders"). Additionally,... Read more
NASHUA, N.H., May 13, 2025 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) ("iCAD" or the "Company") a global leader on a mission to create a world where cancer can’t hide by providing clinically proven AI-powered breast health solutions, today reported its financial and operating results for the three months ended March 31, 2025.
First Quarter 2025 Highlights (Year over Year Performance): Total ARR (Annual Recurring Revenue) was $10.7 million, up 1... Read more
Q1 revenue of $21.9 million, increasing 11% year-over-year
Q1 gross profit increased 9% year-over-year to $13.3 million
Increases full year 2025 guidance to a revenue range between $101 million and $106 million and adjusted EBITDA range between $13 million and $15 million WALTHAM, Mass., May 12, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach... Read more
NEW YORK, May 12, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family building solutions, today announced that Progyny’s Chief Executive Officer, Pete Anevski, and Chief Financial Officer, Mark Livingston, will participate in a fireside chat at the BofA Securities 2025 Health Care Conference on Wednesday, May 14, 2025, at 3:00 P.M. Pacific Time / 6:00 P.M. Eastern Time.
A live audiocast and replay will be available from... Read more
SIGNA™ Sprint, a new wide bore 1.5T MRI scanner, is designed to provide power previously unattainable at 1.5T, for clarity in cardiology and oncology imaging
Advanced high-performance gradient technology leverages built-in AI solutions designed to enable clear, fast imaging for improved workflow HONOLULU / May 12, 2025 / Business Wire / GE HealthCare (Nasdaq: GEHC) today unveiled SIGNA™ Sprint, an FDA 510(k) pending1 ultra-premium wide bore 1.5T high-performance... Read more
Texas Back Institute is a world leader in advancing spine technology, science, and education, as well as patient care
CLARITY is a randomized clinical trial designed to demonstrate Nociscan’s ability to improve surgical outcomes for chronic low back pain
Nociscan aims to become the gold standard in identifying sources of low back pain through MR Spectroscopy (MRS) and Augmented Intelligence (AI) BROOMFIELD, Colo., May 12, 2025 (GLOBE NEWSWIRE) -- Aclarion, Inc.,... Read more
Annual Recurring Revenue (ARR)⁽¹⁾ up 54% YoY to $73.7 million
Total Revenue up 42% YoY to $21.7 million
Adjusted EBITDA⁽¹⁾ up 39% YoY to $5.6 million TORONTO, May 08, 2025 (GLOBE NEWSWIRE) -- Vitalhub Corp. (the “Company” or “VitalHub”) (TSX: VHI) (OTCQX: VHIBF) announced today it has filed its Interim Condensed Consolidated Financial Statements and Management's Discussion and Analysis report for the three months ended March 31, 2025 with the Canadian... Read more
Reports Record Revenue of $324.0 Million, Reflecting 16.5% Growth
Raises Full Year Guidance Due to Strong Start to the Year
Early Selling Season Activity Reflects Ongoing Demand in Women's Health and Family Building Solutions NEW YORK, May 08, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY) (“Progyny” or the “Company”), a global leader in women’s health and family building solutions, today announced its financial results for the three-month period... Read more
WASHINGTON, May 8, 2025 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH) ("Evolent" or the "Company"), a company that specializes in better health outcomes for people with complex conditions through proven solutions that make health care simpler and more affordable, today announced financial results for the three months ended March 31, 2025.
Seth Blackley, Co-Founder and Chief Executive Officer of Evolent stated, "Evolent Health kicked off 2025 with first quarter... Read more
PLEASANTON, Calif., May 8, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today reported financial results for the first quarter ended March 31, 2025.
Recent Updates Revenue was $154.9 million for the first quarter. Excluding $16.8 million related to a patent litigation settlement, revenue was $138.1 million, a 2% decrease from the corresponding period of 2024, primarily driven by a significant decrease in instrument... Read more
Reported sales increased 2.6%; organic sales increased 4.3%
Increases full year organic sales growth outlook by 50 bps to +1.5% to +2.5% ST. PAUL, Minn., May 8, 2025 /PRNewswire/ -- Solventum (NYSE: SOLV) today reported financial results for the first quarter ended March 31, 2025.
First Quarter 2025 Highlights Sales increased 2.6% to $2.1 billion; up 4.3% on an organic basis
GAAP diluted earnings per share of $0.78; adjusted diluted earnings per share of $1.... Read more
Q1 2025 Revenues of $231.3 million, Net Loss of $71.3 million, and Adjusted EBITDA of $142.1 million (Adjusted EBITDA Margin of 61.4%)
Reaffirms full-year guidance MCLEAN, Va. / May 08, 2025 / Business Wire / Claritev Corporation (“Claritev” or the “Company”) (NYSE: CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today reported financial results for the first quarter ended March 31,... Read more
Strong First Quarter Performance and Operating Execution
Enters the State of Arizona
Full-Year 2025 Outlook Raised to Mid- to High End of Guidance Ranges for All Metrics with Attributed Lives Unchanged ARLINGTON, Va., May 08, 2025 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced financial results for the first quarter ended March 31, 2025.
Three Months Ended March 31,
($ in millions, except... Read more
First quarter 2025 revenue of $11.3 million
Adjusted EBITDA1 for first quarter 2025 of $2.7 million, representing an Adjusted EBITDA Margin1 of 24%
Total Number of Clients2 of 784 as at March 31, 2025 TORONTO, May 8, 2025 /CNW/ - LifeSpeak Inc. ("LifeSpeak" or the "Company") (TSX: LSPK), the leading whole-person wellbeing solution for employers, health plans and other organizations, announced today its financial and operational results for the three months... Read more
First Quarter 2025 Revenue In-line; Adjusted EBITDA Margin Beats Previous Guidance; Maintains Full Year 2025 Revenue Guidance Range; Raises Adjusted EBITDA Expectations SANTA MONICA, Calif. / May 07, 2025 / Business Wire / GoodRx Holdings, Inc. (Nasdaq: GDRX) ("we," "us," "our," “GoodRx,” or the “Company”), the leading platform for medication savings in the U.S., has released its financial results for the first quarter of 2025.
First Quarter 2025 Highlights... Read more
MOBILE, Ala. / May 07, 2025 / Business Wire / TruBridge, Inc. (NASDAQ: TBRG), a healthcare solutions company, today announced financial results for the first quarter ended March 31, 2025.
First Quarter 2025 Highlights*
All comparisons are to the quarter ended March 31, 2024, unless otherwise noted Total bookings of $22.0 million compared to $23.6 million
Total revenue of $87.2 million compared to $84.1 million Recurring revenue represented 94% of total revenue... Read more
First Quarter Total Revenue of $59.6 Million, Software Revenue of $48.8 Million
Initial SGR-1505 Phase 1 Clinical Data to be Presented in June
Maintains 2025 Financial Guidance NEW YORK / May 07, 2025 / Business Wire / Schrödinger, Inc. (Nasdaq: SDGR) today announced financial results for the quarter ended March 31, 2025.
“We are very pleased with Schrödinger’s performance in the first quarter of 2025, with strong software and drug discovery revenue growth.... Read more
SALT LAKE CITY, May 07, 2025 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (“Health Catalyst,” Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported financial results for the quarter ended March 31, 2025.
“For the first quarter of 2025, I am pleased by our strong financial results, including total revenue of $79.4 million and Adjusted EBITDA of $6.3 million, with these results beating our quarterly... Read more
The partnership integrates Claritev’s innovative solutions with Lantern’s Specialty Care Platform to optimize healthcare costs for Lantern’s footprint. MCLEAN, Va. / May 07, 2025 / Business Wire / Claritev Corporation (“Claritev” or the “Company”) (NYSE: CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today announced an agreement with Lantern, a Specialty Care Platform that helps... Read more
AstraZeneca, Bayer, Boehringer Ingelheim, Eli Lilly and Company, and more share strategies for more connected customer experiences across sales, marketing, and medical PLEASANTON, Calif., May 6, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced its keynote speakers for the 2025 Veeva Commercial Summit, May 13-14 in Boston. Leading and emerging biopharmas will share innovations and strategies to drive more coordinated customer engagement through... Read more
BOSTON and ROLLE, Switzerland, May 6, 2025 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and leader in data-driven medicine, today reported financial results for the first quarter ended March 31, 2025.
First Quarter 2025 Financial Results Revenue was $17.8 million, up 13% year-over-year or 15% on a constant currency basis
Gross margin was 68.7% on a reported basis and 75.7% on an adjusted basis, up from 65.9% and 70.5% in the... Read more
Omnicell delivers solid first quarter financial results
Results exceed previously issued first quarter 2025 guidance for total revenues and non-GAAP EPS
Updates full year 2025 non-GAAP EBITDA and non-GAAP EPS guidance FORT WORTH, Texas / May 06, 2025 / Business Wire / Omnicell, Inc. (NASDAQ:OMCL) (“Omnicell,” “we,” “our,” “us,” “management,” or the “Company”), a leader in transforming the pharmacy and nursing care delivery model, today announced... Read more
Total net revenue of $261.4 million (total net revenue excluding Contigo Health* of $255.3 million)
GAAP net income from continuing operations of $27.6 million, or $0.32 per fully diluted share
Adjusted earnings per share excluding Contigo Health* of $0.46
Net cash provided by operating activities from continuing operations of $307.8 million and free cash flow* of $130.3 million for the first nine months of fiscal-year 2025
Increasing adjusted EBITDA and adjusted EPS... Read more
SOMERSET, N.J., May 06, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (Nasdaq: CCLD, CCLDO), a leader in healthcare technology and generative AI solutions, today announced strong financial results for the three months ended March 31, 2025. CareCloud’s strategic execution, AI-driven innovation, and disciplined financial management have fueled a transformational turnaround, positioning the Company for sustained profitability and long-term growth. Management will discuss... Read more
NASHVILLE, Tenn. / May 05, 2025 / Business Wire / HealthStream, Inc. (the "Company") (Nasdaq: HSTM), a leading healthcare technology platform for workforce solutions, announced today results for the first quarter ended March 31, 2025.
First Quarter 2025 Revenues of $73.5 million in the first quarter of 2025, up 1.0% from $72.8 million in the first quarter of 2024
Operating income of $4.4 million in the first quarter of 2025, down 23.1% from $5.7 million in the first... Read more
